Knowledge Graph

Graph explorer

Search resolved entities, walk their edges, and read the sentence behind every one.

Entities25 of 207,987

Entity

ampreloxetine

product1 mentionslast seen Sep 23, 2026

Therapeutic product that is subject to contingent value rights.

Relationships 1

Theravance Biopharma, Inc.developsampreloxetine80% confidence1 source

Relationship

Theravance Biopharma, Inc.developsampreloxetine

80% confidence1 supporting mentions

Either name opens that entity’s relationships.

Sources 1

filingSEC EDGARSep 23, 2026Theravance Biopharma, Inc. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 2.01: Completion of Acquisition or Disposition of Assets; Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; Item 3.03: Material Modifications to Rights of Security Holders; Item 5.01: Changes in Control of Registrant; Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
any therapeutic product that contains ampreloxetine